Tharimmune Inc. announced on February 5, 2026 that Chief Executive Officer Mark Wendland will also serve as Chairman of the Board, while former financial‑technology executive Angela Radkowski has been named Chief Operating Officer. Vincent LoPriore, the former Chairman, will remain on the board as an independent director.
Radkowski brings a decade of experience scaling operations for high‑frequency trading and asset‑management firms, having held senior roles at DRW Holdings and Citadel. Her appointment is intended to strengthen Tharimmune’s operational execution as the company expands its presence on the Canton Network, a public blockchain designed for institutional finance.
The leadership changes dovetail with Tharimmune’s dual‑focus strategy. The company has positioned itself as the first publicly traded entity to own Canton Coin, operate as a Super Validator, and invest in applications built on the Canton Network. The moves also follow the company’s recent restoration of Nasdaq board‑independence compliance on February 2, reinforcing governance as it pursues aggressive digital‑asset growth.
Mark Wendland said the elevation to Chairman “will enable us to accelerate the execution of our Canton‑Network‑aligned digital‑asset strategy and modernize financial market infrastructure.” Radkowski added, “The Canton Network introduces a new model for institutional finance, and I am excited to build the operational foundation required to support this transformation.”
With the CEO now also chairing the board, Tharimmune aims to streamline decision‑making and align its biotech research pipeline with its expanding digital‑asset operations, positioning the company for accelerated growth across both segments.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.